Arysta LifeScience, Laboratoires Goëmar To Co-Distribute Biostimulants And Biocontrols
Arysta LifeScience & Laboratoires Goëmar will now have exclusive European distribution rights to several products in each company's respective pipeline.
December 21, 2012
Arysta LifeScience Corp. and Laboratoires Goëmar have announced the conclusion of two agreements to develop and distribute Biostimulants and Biocontrol products. Under the first agreement, Arysta LifeScience will have exclusivity for several Goëmar products related to Physio Activator Technology and Natural Protect Technology. Under the second agreement Laboratoires Goëmar will have exclusivity for several Arysta LifeScience products related to Biostimulants and Biocontrol technologies. The two contracts also provide the possibility to expand cooperation to new technologies under development.
Specifically, Arysta LifeScience acquires exclusive rights for identified products to operate in Central Europe (Poland, Czech Republic, Slovakia, Romania, Baltic Countries and Hungary) and the Commonwealth of Independent States (Russia, Ukraine, Belarus, Moldova and Kazakhstan). Laboratoires Goëmar acquires exclusivity to develop and distribute ATONIK in France, and access to Arysta LifeScience Biostimulant and Biocontrol products in France plus other countries in Western Europe.
“This mutual agreement is the result of a long, fruitful relationship between our companies,” said Kevin Smith, CEO of Arysta LifeScience SAS and business unit head of Europe for Arysta LifeScience. “It strengthens the presence of Arysta LifeScience in this market segment with access to modern technologies. Customers may expect ‘tailor-made’ technologies delivering benefits to various crops."
“These contracts, combining technologies and market presence strengths of both companies, should facilitate broader farmer access to innovative sustainable solutions for their crops, accelerate Goëmar sales growth in Central and Eastern Europe, and offer Goëmar sales force and customers a broader portfolio of solutions,” said Jean-Pierre Princen, CEO Laboratoires Goëmar.